![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1496022
¼¼°èÀÇ ÇÕ¼º ¼ö¼ú¿ë Àå°© ½ÃÀå ¿¹Ãø(2024-2029³â)Synthetic Surgical Glove Market - Forecasts from 2024 to 2029 |
ÇÕ¼º ¼ö¼ú¿ë Àå°© ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 9.15%¸¦ ±â·ÏÇÒ Àü¸ÁÀ̸ç, 2022³â ½ÃÀå ±Ô¸ð 18¾ï 304¸¸ 2,000´Þ·¯¿¡¼ 2029³â¿¡´Â 33¾ï 2,764¸¸ 6,000´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
´ÏÆ®¸±°ú ³×¿ÀÇÁ·»°ú °°Àº ÇÕ¼º °íºÐÀÚ·Î ¸¸µé¾îÁø ÇÕ¼º ¼ö¼ú Àå°©Àº Àü¹®ÀÇ¿Í ¿Ü°ú ÀÇ»ç, ȯÀÚÀÇ ºÒ°áÀ» ÇÇÇϱâ À§ÇØ ¼ö¼ú Áß¿¡ »ç¿ëµË´Ï´Ù. À̵éÀº ³·Àº ¾Ë·¹¸£±â¼º, ¿ì¼öÇÑ ³»ÈÇмº, °µµ, À§´ëÇÑ Àç·áÀÇ ¿µÇâ·ÂÀ» Á¦°øÇÏ°í ´Ù¾çÇÑ ÀÇ·á ¹æ¹ýÀ» À§ÇØ ÇÕ¸®ÀûÀ¸·Î ¸¸µå´Â ÀÏȸ¿ë Àå°©ÀÔ´Ï´Ù. ÆÄ¿ì´õ ÇÁ¸® ¿É¼Çµµ ÀÖÀ¸¸ç ÆÄ¿ì´õ °ü·Ã ÇÕº´ÁõÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¼¼°è¿¡¼ ²÷ÀÓ¾ø´Â Áúº´°ú »ýȰ ¾ç½ÄÀÇ º¯È°¡ ÁÖ¿ä ¿äÀÎÀÌ µÇ¾î ¼ö¼ú¿ë Àå°© »ê¾÷Àº È®´ëµÇ°í ÀÖ½À´Ï´Ù.
¶Ç ´Ù¸¥ ÁÖ¿ä ¿äÀÎÀº °Ç° °ü¸® Àü¹®°¡µé »çÀÌ¿¡¼ ¶óÅØ½º °ú¹ÎÁõÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â °ÍÀÔ´Ï´Ù. ¾Ë·¹¸£±â´Â ÀÇ·á Á¾»çÀÚ»Ó¸¸ ¾Æ´Ï¶ó ȯÀÚµµ ±«·ÓÈü´Ï´Ù. ÇÕ¼º ¼ö¼ú Àå°©À» Âø¿ëÇÏ¸é ¾Ë·¹¸£±â ¹ßº´ °¡´É¼ºÀÌ ³·¾ÆÁý´Ï´Ù. ´Ù¸¥ Àå°©¿¡ ºñÇØ ¸¶Âû°ú ¸¶¸ð°¡ Àû°í ¾ÈÀüÇϱ⠶§¹®¿¡ ÀÌ·¯ÇÑ Àå°©ÀÇ »ç¿ëÀº À¯ÀÍÇÕ´Ï´Ù.
ÇÕ¼º ¼ö¼ú Àå°© ½ÃÀåÀº ¶óÅØ½º °ú¹ÎÁõ ÀÇ½Ä Áõ°¡, ³·Àº ¾Ë·¹¸£±â¼º ¿É¼Ç¿¡ ´ëÇÑ ±â¿ï±â ¹× °íµµ·Î Áøº¸µÈ ±â´É¿¡ ´ëÇÑ ¿ä±¸·Î ÀÎÇØ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. COVID-19ÀÇ À翬¼Ò¸¦ °í·ÁÇÏ¸é °³º° ¹æ¾î±â±¸´Â ½ÇÁ¦·Î Á߿伺ÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ È帧Àº ÇöÀúÇÑ ±ÔÁ¦ ±âÁØ, Áö¸®Àû Áö¿ª ¹× ÀÌ·¯ÇÑ Àå°©ÀÇ Á¦Á¶¿¡¼ Çõ½ÅÀûÀÎ ±â¼ú Áøº¸¿¡ µû¶ó ´Þ¶óÁú ¼ö ÀÖ½À´Ï´Ù.
2023³â 9¿ù, ¼¼°èº¸°Ç±â±¸(WHO)´Â ºñ°¨¿°¼º Áúȯ(NCDs)¿¡ °üÇÑ µ¥ÀÌÅ͸¦ ¹ßÇ¥ÇßÀ¸¸ç, Àü ¼¼°è »ç¸ÁÀÚÀÇ 74%°¡ NCDs¿¡ ÀÇÇÑ °ÍÀ¸·Î, ¸Å³â 4,100¸¸ ¸í¿¡ ÇØ´ç . À̰ÍÀº ´ç´¢º´, °íÇ÷¾Ð, ½ÉÇ÷°ü Áúȯ, °íÄÝ·¹½ºÅ×·Ñ, ¾Ï µîÀÇ ÁÖ¿ä ¸¸¼º ÁúȯÀ» ¾Î°í Àִ ȯÀÚ°¡ ¾ÕÀ¸·Îµµ Áõ°¡ÀÇ ±æÀ» µû¶ó°¥ °ÍÀ» ³ªÅ¸³À´Ï´Ù.
ÀÌ Áõ°¡ À̿ܿ¡ ¾Ï, È£Èí±â Áúȯ, ´ç´¢º´ µîÀÇ ºñÀü¿°¼º Áúȯµµ ȯÀÚ¼ö°¡ Áõ°¡Çϰí ÀÖ´Â ÁúȯÀÔ´Ï´Ù. WHO¿¡ µû¸£¸é ÀÌ·¯ÇÑ Áúº´À¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö´Â °¢°¢ 930¸¸¸í, 410¸¸¸í, 150¸¸¸íÀÔ´Ï´Ù.
¶ÇÇÑ ³ëÀÎ Áõ°¡µµ ȯÀÚ ¼ö Áõ°¡¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. Àα¸¹®Á¦¿¬±¸¼ÒÀÇ 2020³â 3¿ù Á¶»ç µ¥ÀÌÅÍ¿¡ µû¸£¸é 65¼¼ ÀÌ»óÀÇ Àα¸°¡ ¼¼°è¿¡¼ °¡Àå ¸¹Àº °ÍÀº ¾Æ½Ã¾Æ¿Í À¯·´, ´ÙÀ½À¸·Î ¸¹Àº °ÍÀº ÀϺ»ÀÇ 28%, ÀÌÅ»¸®¾Æ°¡ 23%ÀÔ´Ï´Ù. °Ô´Ù°¡ Å©·Î¾ÆÆ¼¾Æ, ±×¸®½º, ÀÌÅ»¸®¾Æ, Æ÷¸£Åõ°¥, ¼¼¸£ºñ¾Æ, ½ºÆäÀÎ, ½½·Îº£´Ï¾Æ, ¸ôŸ·Î ±¸¼ºµÈ ³²À¯·´ ±¹°¡µéÀº 65¼¼ ÀÌ»ó Àα¸ÀÇ 21%¸¦ Â÷ÁöÇØ ÃÖ°í·É Áö¿ªÀ¸·Î µÇ¾î ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ö¼ú ¸ñÀûÀÇ ÀÇ·á °ü±¤µµ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¶ÇÇÑ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¼¼°è ÇÕ¼º ¼ö¼ú Àå°© ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ÀÇ·á Á¾»çÀÚÀÇ ¶óÅØ½º ¾Ë·¹¸£±â Áõ°¡ÀÔ´Ï´Ù. ¶óÅØ½º ¾Ë·¹¸£±â´Â ¶óÅØ½º Àå°©ÀÇ Á¦Á¶¿¡ ÀÚÁÖ »ç¿ëµÇ´Â õ¿¬ °í¹« ¶óÅØ½º¿¡ ÇÔÀ¯ µÈ ´Ü¹éÁú¿¡ ´ëÇÑ °ú¹Î ¹ÝÀÀÀÔ´Ï´Ù. ÀÇ»ç, °£È£»ç ¹× °Ë»ç ±â»ç¸¦ Æ÷ÇÔÇÑ °Ç° °ü¸® Á¾»çÀÚ´Â Àå½Ã°£ ³ëÃâ·Î ÀÎÇØ ÀÌ·¯ÇÑ ¾Ë·¹¸£±â¸¦ ÀÏÀ¸Å³ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ÀÌ·¯ÇÑ ¾Ë·¹¸£±â´Â Áï½Ã ¶Ç´Â ´À¸° °ú¹Î ¹ÝÀÀÀ» ÀÏÀ¸Å°°í, µÎµå·¯±â, °¡·Á¿òÁõ, ¾Æ³ªÇʶô½Ã½º¿Í °°Àº Áõ»óÀ» À¯¹ßÇÕ´Ï´Ù.
°Ç° °ü¸® Á¾»çÀڴ ȯÀÚÀÇ ¾ÈÀüÀ» Áß½ÃÇÏ°í ±³Â÷ ¿À¿°À» ÇÇÇϱâ À§ÇØ ÇÕ¼º ¼ö¼ú Àå°©À» »ç¿ëÇØ¾ßÇÕ´Ï´Ù. ¶ÇÇÑ ½Ã¼³Àº ¹ýÀû ±âÁØÀ» ÃæÁ·Çϰí Á÷¿øÀÇ °Ç°°ú ¾ÈÀüÀ» º¸È£Çϱâ À§ÇØ ÇÕ¼º Àå°©ÀÇ »ç¿ëÀ» °áÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¶óÅØ½º Àå°©À» Âø¿ëÇÏ¸é ¾Ë·¹¸£±â ¹ÝÀÀÀ» ÀÏÀ¸Å³ ¼ö ÀÖÁö¸¸,ÀÌ Àå°©À» »ç¿ëÇÏ´Â °Ç° °ü¸® ÀÛ¾÷ÀÚ´Â ¸¹Àº °¨¿°ÀÇ È®»êÀ» ¸·À» ¼ö ÀÖ½À´Ï´Ù. ¶óÅØ½º¸¦ ¸¸Áö¸é ¹°Áý, ½ÀÁø, ¹ßÁø, ¹ßÀû, °¡·Á¿òÁõ, º×±â µîÀÌ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¶óÅØ½º¿ÍÀÇ Á¤±âÀû ÀÎ Á¢ÃËÀÌ Áõ°¡ÇÏ¸é ¶óÅØ½º ¾Ë·¹¸£±â¸¦ ÀÏÀ¸Å³ À§ÇèÀÌ Å©°Ô Áõ°¡ÇÕ´Ï´Ù.
¶ÇÇÑ ÃÖ±Ù ¸î ³âµ¿¾È °Ç° °ü¸® ¾÷°è Àüü¿¡¼ ÀÌ·¯ÇÑ ¹ÝÀÀÀ̺¸°íµÇ´Â °Ç¼ö°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ¶óÅØ½º ¾Ë·¹¸£±â Çùȸ¿¡ µû¸£¸é õ¿¬ °í¹« ¶óÅØ½º °ú¹ÎÁõÀº ¹Ì±¹ ³» ÀÇ·á Á¾»çÀÚÀÇ 8-17%°¡ º´À» ¾Î°í ÀÖ´Ù°í ÇÕ´Ï´Ù. ±× °á°ú ¼¼°è ¿©·¯ º´¿øÀÌ ÇÕ¼º(ºñ ¶óÅØ½º) ÀÇ·á Àå°©À» »ç¿ëÇϱ⠽ÃÀÛÇß½À´Ï´Ù.
ÁÖ¿ä ÁöÃâÀº ÇÕ¼º ¼ö¼ú Àå°©À» »ý»êÇÏ´Â ¿øÀç·á ºñ¿ëÀÔ´Ï´Ù. ¾ÆÁú»ê¿°Àº Á¦Ç°ÀÇ Á¦Á¶¿¡ »ç¿ëµÇ´Â ÀϹÝÀûÀÎ ¿ø·á Áß ÇϳªÀÌ¸ç Æú¸® À̼ÒÇÁ·»°ú ³×¿ÀÇÁ·»ÀÌ À̾îÁý´Ï´Ù. ´ÏÆ®¸± ¼ÒÀç´Â õ¿¬ °í¹«ÀÇ ´ë¿ëǰÀ̸ç, ¶óÅØ½º ¼ÒÀç¿Í ºñ½ÁÇÑ Æ¯¼ºÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àå°©ÀÇ °¡°ÝÀº ¾Ë·¹¸£±â À§ÇèÀ» Á¦°ÅÇÏ´Â µ¥ »ç¿ëµÇ´Â ¾ÆÁú»ê¿°°ú °°Àº ¿ø·á ¼ººÐ¿¡ µû¶ó ´Ù¸¨´Ï´Ù. ¿ø·áÀÇ Ç°ÁúÀº °µµ, µÎ²², À¯¿¬¼º, °¨¿° ÀüÆÄ¿¡ ¿µÇâÀ» ¹ÌÄ¡°í Àå°©À» Âø¿ëÇÏ´Â ¸ñÀûÀ» ÆÄ±«Çϱ⠶§¹®¿¡ ¹æÇعÞÁö ¾Ê½À´Ï´Ù. ¶ÇÇÑ Àå°©ÀÇ Ç°ÁúÀÌ ÀÏÁ¤ÇÏ´Ù´Â °ÍÀ» º¸ÀåÇϱâ À§ÇØ ´ç±¹ÀÇ ±ÔÄ¢ÀÌ ÀÌ ºÐ¾ß¿¡ ºÎ°úµË´Ï´Ù.
The synthetic surgical glove market is projected to witness a CAGR of 9.15% during the forecast period to reach a total market size of US$3,327.646 million by 2029, up from US$1,803.042 million in 2022.
Synthetic surgical gloves, which are made of synthetic polymers such as nitrile and neoprene, are utilized amid surgeries to avoid defilement of the specialist, surgeons, and the patient. These are disposable gloves that offer hypoallergenic properties, superior chemical resistance, strength, and great material affectability, making them reasonable for different medical methods. They are accessible in powder-free choices to decrease powder-related complications. The developing predominance of constant illnesses and changes in the way of life around the globe are considered the key drivers for the manufactured surgical gloves industry expansions.
Another major variable is the increasing latex hypersensitivity among healthcare specialists. Allergies can bother not only healthcare personnel but also patients. Allergy development is less likely when synthetic surgical gloves are worn. The utilization of these gloves is profitable as they are safer to friction and low wear than other gloves.
The synthetic surgical gloves market has increased due to rising awareness of latex hypersensitivities, the inclination for hypoallergenic options, and the requirement for advanced and progressed features. Individual defensive equipment has gotten to be indeed more significant in light of the COVID-19 flare-up. Market flow may shift based on prominent regulatory standards, geographical regions, and innovative technological progressions in the manufacturing of these gloves.
Iin September 2023, the World Health Organization(WHO) released data on Non-Communicable Diseases (NCDs) which stated that 74% of all deaths globally are due to NCDs which is equivalent to 41 million people every year out of which about 17.9 million people die each year from Cardiovascular disease which is accounts as the most death-causing disease globally. This shows that there will be a constant upward movement of patients suffering from major chronic diseases like diabetes, high blood pressure, cardiovascular disease, high cholesterol, and cancer, amongst others.
In addition to that rise, some other non-communicable diseases such as cancer, respiratory diseases, and diabetes are the diseases due to which the number of patients has increased. According to WHO, deaths Caused due to these diseases are 9.3 million, 4.1 million, and 1.5 million, respectively.
Moreover, the increasing number of older age people is also further augmenting the rising number of patients. According to Population Reference Bureau survey data from March 2020, the worlds oldest populations that are aged 65 and more are in Asia and Europe, the next oldest population is 28 percent in Japan, and Italy comes after with 23 percent whereas Greece, Portugal, and Finland make up the final five places, each with a little less than 22% of the older population. Further, countries of Southern Europe, consisting of Croatia, Greece, Italy, Portugal, Serbia, Spain, Slovenia, and Malta with 21% of the population aged 65+ are considered the oldest region. Further, the increasing medical tourism is also being observed for surgery purposes which will also have a positive impact on the market.
A primary driver of the worldwide synthetic surgical glove market is the increasing incidence of latex allergy among medical professionals. Allergies to latex are hypersensitivity responses to proteins found in natural rubber latex, which is frequently used to make latex gloves. Due to extended exposure, healthcare workers-including physicians, nurses, and laboratory personnel-are more likely to acquire these allergies. These allergies can cause hypersensitivity reactions that are either immediate or delayed, resulting in symptoms including hives, itching, and anaphylaxis.
Healthcare professionals should use synthetic surgical gloves in order to emphasize patient safety and avoid cross-contamination. Facilities may also decide to use synthetic gloves in order to meet legal standards and protect the health and safety of their employees.
Although wearing latex might cause allergic reactions, healthcare workers who use these gloves can help stop the spread of many infectious diseases. When it comes into touch with latex, it can get blisters, eczema, rashes, redness, itching, and swelling. Furthermore, increased regular interaction with latex has been linked to a substantial risk of developing a latex allergy.
Further,in recent years, the number of documented occurrences of such responses across the healthcare industry has increased. According to the American Latex Allergy Association, natural rubber latex sensitization affects 8-17 percent of healthcare professionals in the United States. As a result, several hospitals throughout the world have begun using synthetic (non-latex) medical gloves.
The primary expenditure is on raw materials for manufacturing synthetic surgical gloves. Nitrite is one of the popular raw elements used in the product's manufacture, followed by polyisoprene and neoprene. The nitrile material is a substitute for natural rubber and has properties similar to latex material. Also, the price of gloves is determined by the raw ingredient, such as nitrite, which is used to eliminate the risk of allergy. The quality of the raw material cannot be hindered as it will impact the strength, thickness, flexibility, and infection transmission, ruining the purpose of wearing gloves. Authority rules have also been imposed on the sector to ensure that the gloves are of a consistent quality.